- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT00706121
S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000 (ACP)
S0000D: A Study of the Effect of Vitamin E and/or Selenium on Adenomatous Colorectal Polyps (ACP) in Participants Enrolled in SELECT
RATIONALE: Studying tissue samples in the laboratory from participants receiving treatment on the Selenium and Vitamin E Cancer Prevention Trial (SELECT) SWOG-S0000 may help doctors predict a participant's response to treatment and help plan the best treatment.
PURPOSE: This phase III trial is studying the effect of vitamin E and/or selenium on colorectal polyps in men enrolled on SELECT Trial SWOG-S0000.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
OBJECTIVES:
Primary
- To assess the effect of selenium on colorectal adenoma (CRA) occurrence.
- To assess the effect of selenium on number, location, size, histologic type, and degree of dysplasia of CRA.
- To assess the effect of selenium on colorectal cancer (CRC) incidence.
Secondary
- To assess the effect of vitamin E on CRA occurrence.
- To assess the effect of vitamin E on CRC incidence.
Tertiary
- To explore the effect modification of selenium and vitamin E by aspirin on CRA occurrence.
- To explore the effect modification of selenium and vitamin E by body mass index.
OUTLINE: This is a multicenter study.
Endoscopically obtained tissue samples are reviewed by study pathologists to confirm the presence (or absence) of a colorectal adenoma (CRA). If a CRA is present, the number, location, size, histology, and degree of dysplasia are documented. The CRA is also reviewed to exclude a diagnosis of colorectal cancer.
Additional data, including aspirin use, height and weight, date of birth, and other demographic and baseline characteristics, is also obtained. Participants' medical records are reviewed periodically.
Participants are followed annually.
Tipo de estudio
Inscripción (Actual)
Fase
- Fase 3
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Arizona
-
Tucson, Arizona, Estados Unidos, 86724
- Arizona Cancer Center
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
DISEASE CHARACTERISTICS:
- Enrolled on the Selenium and Vitamin E Cancer Prevention Trial (SELECT) SWOG-S0000
- Screened by lower endoscopy (i.e., sigmoidoscopy and/or colonoscopy) after randomization on SELECT trial
PATIENT CHARACTERISTICS:
- Willing to sign an applicable medical records release form
- Willing to allow the release of tissue for central pathology review of resected polyps and endoscopic biopsies
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Cuadruplicar
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Vitamin E + selenium placebo
Vitamin E and selenium placebo daily for 7 - 12 years
|
400 IU daily by mouth for 7 - 12 years
Otros nombres:
1 pill by mouth daily for 7 - 12 years
Otros nombres:
|
|
Experimental: Selenium + vitamin E placebo
Selenium and vitamin E placebo daily for 7 - 12 years
|
200 mcg daily for 7 - 12 years
Otros nombres:
1 pill by mouth daily for 7 - 12 years
Otros nombres:
|
|
Experimental: Vitamin E + selenium
Vitamin E and selenium daily for 7 - 12 years
|
400 IU daily by mouth for 7 - 12 years
Otros nombres:
200 mcg daily for 7 - 12 years
Otros nombres:
|
|
Comparador de placebos: Vitamin E placebo + selenium placebo
Vitamin E placebo and selenium placebo daily for 7 - 12 years
|
1 pill by mouth daily for 7 - 12 years
Otros nombres:
1 pill by mouth daily for 7 - 12 years
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Effect of Selenium on Colorectal Adenoma (CRA) Occurrence, Analyzed by Active Selenium vs. Selenium Placebo
Periodo de tiempo: From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
|
|
Effect of Selenium on Advanced Neoplasia, Analyzed by Active Selenium vs. Selenium Placebo
Periodo de tiempo: From 1 year post randomization through study completion
|
Adenomas with diameter >=1cm or any adenoma with villous features or high-grade dysplasia
|
From 1 year post randomization through study completion
|
|
Effect of Selenium and/or Vitamin E on Colorectal Cancer (CRC) Incidence
Periodo de tiempo: From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
|
|
Effect of Selenium on Occurrences of Multiple (>2) Adenomas
Periodo de tiempo: From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Effect of Vitamin E on CRA Occurrence, Analyzed by Active Vitamin E vs. Vitamin E Placebo
Periodo de tiempo: From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
Otras medidas de resultado
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Effect Modification of Selenium by Body Mass Index on CRA Occurrence, Analyzed by Active Selenium vs. Selenium Placebo
Periodo de tiempo: From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
|
Effect Modification of Selenium by Aspirin on CRA Occurrence, Analyzed by Active Selenium vs. Selenium Placebo
Periodo de tiempo: From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
|
Effect Modification of Vitamin E by Body Mass Index on CRA Occurence, Analyzed by Active Vitamin e vs. Vitamin e Placebo
Periodo de tiempo: From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
|
Effect Modification of Vitamin E by Aspirin on CRA Occurrence, Analyzed by Active Vitamin e vs. Vitamin e Placebo
Periodo de tiempo: From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- CDR0000593329
- U10CA037429 (Subvención/contrato del NIH de EE. UU.)
- S0000D (Otro identificador: SWOG)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .